{
    "eid": "2-s2.0-85044069522",
    "title": "The Cytochrome P450 3A5 Non-Expressor Kidney Allograft as a Risk Factor for Calcineurin Inhibitor Nephrotoxicity",
    "cover-date": "2018-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Allograft clearance",
        "Calcineurin inhibitor nephrotoxicity",
        "CYP3A5 genotypes",
        "Donor genotype",
        "Kidney transplantation",
        "Precision medicine"
    ],
    "authors": [
        "Suwasin Udomkarnjananun",
        "Natavudh Townamchai",
        "Pajaree Chariyavilaskul",
        "Kroonpong Iampenkhae",
        "Krit Pongpirul",
        "Boonchoo Sirichindakul",
        "Kamol Panumatrassamee",
        "Jakapat Vanichanan",
        "Yingyos Avihingsanon",
        "Somchai Eiam-Ong",
        "Kearkiat Praditpornsilpa"
    ],
    "citedby-count": 8,
    "ref-count": 33,
    "ref-list": [
        "Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results",
        "Reduced exposure to calcineurin inhibitors in renal transplantation",
        "Calcineurin inhibitor minimization in the Symphony study: Observational results 3 years after transplantation",
        "Immunosuppressive drugs for kidney transplantation",
        "Calcineurin inhibitor nephrotoxicity",
        "Therapeutic monitoring of calcineurin inhibitors for the nephrologist",
        "Effect of CYP3A5 3 on kidney transplant recipients treated with tacrolimus: A systematic review and meta-analysis of observational studies",
        "Cytochrome P450 3A polymorphisms and immunosuppressive drugs: An update",
        "CYP3A5 and ABCB1 polymorphisms in donor and recipient: Impact on Tacrolimus dose requirements and clinical outcome after renal transplantation",
        "CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients",
        "A simple novel technique to estimate tacrolimus dosages during the early post kidney transplantation period",
        "Lower tacrolimus daily dose requirements and acute rejection rates in the CYP3A5 nonexpressers than expressers",
        "Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus",
        "CYP3A5 genotype-phenotype analysis in the human kidney reveals a strong site-specific expression of CYP3A5 in the proximal tubule in carriers of the CYP3A5 1 allele",
        "Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro",
        "Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity",
        "Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity",
        "A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype",
        "The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations",
        "Banff 07 classification of renal allograft pathology: Updates and future directions",
        "Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions",
        "Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients",
        "Genetic variability in CYP3A5 and its possible consequences",
        "Pharmacogenetics of calcineurin inhibitors in renal transplantation",
        "The genetic determinants of the CYP3A5 polymorphism",
        "Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients",
        "Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients",
        "Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients",
        "The influence of living donor SHROOM3 and ABCB1 genetic variants on renal function after kidney transplantation",
        "Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation",
        "Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation",
        "Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients",
        "Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: A possible interaction between donor and recipient genetic polymorphisms"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University"
    ]
}